Irvine, California Clinical Trials

A listing of Irvine, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 46 clinical trials
None

University of Southern California
 (7.6 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

University of Southern California
 (7.6 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

combination therapy
measurable disease
testosterone
antiandrogen therapy
prostatic neoplasms, castration-resistant
The University of California, Irvine Medical Center
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

fibrosis
fibroscan
vcte
fatty liver
hepatic fibrosis
Conquest Clinical Research
 (6.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Development and Analysis of a Stool Bank for Cancer Patients

This study is aimed at understanding the impact of gut microbiota on efficacy of cancer therapies, in particular checkpoint inhibitors, and using the resulting information to design microbial immunotherapies. Although animal models are of use to determine the influences of gut and other microbiota on cancer treatment modalities, they are …

cancer immunotherapy
pembrolizumab
immunotherapies
cancer treatment
Compassionate Care Research Group, Inc.
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Patient-Derived Xenografts to Reduce Cancer Health Disparities

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.

bladder cancer
cancer
liver cancer
lung cancer
gastric cancer
UC Irvine Health/Chao Family Comprehensive Cancer Center
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations